SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-12-011534
Filing Date
2012-11-13
Accepted
2012-11-13 13:09:28
Documents
11
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q ahro_10q-093012.htm 10-Q 738858
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 16429
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 16598
4 EXHIBIT 32.1 ex32-1.htm EX-32.1 7666
5 EXHIBIT 32.2 ex32-2.htm EX-32.2 7242
  Complete submission text file 0001437749-12-011534.txt   5623747

Data Files

Seq Description Document Type Size
6 ahro-20120930.xml EX-101.INS 779180
7 ahro-20120930.xsd EX-101.SCH 44100
8 ahro-20120930_cal.xml EX-101.CAL 27534
9 ahro-20120930_def.xml EX-101.DEF 275405
10 ahro-20120930_lab.xml EX-101.LAB 394645
11 ahro-20120930_pre.xml EX-101.PRE 283971
Mailing Address 2301 DUPONT DRIVE, SUITE 525 IRVINE CA 92612
Business Address 2301 DUPONT DRIVE, SUITE 525 IRVINE CA 92612 (949) 525-5471
AtheroNova Inc. (Filer) CIK: 0001377053 (see all company filings)

IRS No.: 201915083 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52315 | Film No.: 121197590
SIC: 2834 Pharmaceutical Preparations